Related Experiment Videos
P53 tumour suppressor gene expression in hyperparathyroidism
P Subramaniam1, S Wilkinson, J J Shepherd
1University Department of Surgery, University of Tasmania, Hobart, Australia.
Background:
Mutations of the p53 tumour suppressor gene lead to the loss of control of normal cellular proliferation and differentiation and have been shown to be associated with the development of malignancy.
Method:
Archival paraffin resection specimens from 86 cases of hyperparathyroidism treated surgically using the rabbit polyclonal CMI antibody were investigated to detect p53 immunoreactivity in these sections.
Results:
Eighteen of the 86 sections examined (21%) showed nuclear immunoreactivity. No correlation was detected between tumour histology and p53 immunoreactivity (P = 0.45), nor was there any correlation between tumour clonality and immunoreactivity (P = 0.54). Multiple endocrine neoplasia type 1 (MEN 1) status did not correlate with p53 immunoreactivity. A significant correlation between p53 immunoreactivity and preparathyroidectomy calcium levels of > 1.5 mmol/L was detected (P < 0.005) although no correlation was noted between p53 immunoreactivity and higher levels of preparathyroidectomy intact parathyroid hormone (PTH) levels.
Conclusion:
A relationship is postulated between abnormal serum calcium regulation and p53 mutation in hypercalcaemic states associated with hyperparathyroidism.
Insights
p53 gene mutations are linked to cancer. In hyperparathyroidism, p53 immunoreactivity correlated with high calcium levels, suggesting a role in abnormal calcium regulation.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Mutations in the p53 tumor suppressor gene disrupt cellular control, contributing to malignancy.
- p53 gene mutations are implicated in various cancers.
Purpose of the Study:
- To investigate the presence and significance of p53 immunoreactivity in hyperparathyroidism.
- To explore potential correlations between p53 status and clinical/pathological features of hyperparathyroidism.
Main Methods:
- Analysis of archival paraffin-embedded tissue specimens from 86 surgically treated hyperparathyroidism cases.
- Detection of p53 immunoreactivity using a rabbit polyclonal CMI antibody.
Main Results:
- p53 nuclear immunoreactivity was observed in 21% (18/86) of the examined sections.
- No significant correlation was found between p53 immunoreactivity and tumor histology, clonality, or Multiple Endocrine Neoplasia type 1 (MEN 1) status.
- A significant correlation was detected between p53 immunoreactivity and pre-operative serum calcium levels > 1.5 mmol/L (P < 0.005).
Conclusions:
- A relationship is suggested between abnormal serum calcium regulation and p53 mutations in hyperparathyroidism.
- p53 alterations may play a role in the pathogenesis of hypercalcemic states associated with hyperparathyroidism.